![Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial - The Lancet Neurology Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000992368/2003665596/gr1.gif)
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial - The Lancet Neurology
![References in Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial - The Lancet Neurology References in Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0c691b93-11b6-4ed9-b038-d78a8164642a/gr1.jpg)
References in Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial - The Lancet Neurology
![Frontiers | Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study | Psychiatry Frontiers | Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study | Psychiatry](https://www.frontiersin.org/files/Articles/653026/fpsyt-12-653026-HTML/image_m/fpsyt-12-653026-g001.jpg)
Frontiers | Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study | Psychiatry
![PDF) Review of the available evidence on Lamotrigine for Epilepsy FOR THE WHO MODEL LIST OF ESSENTIAL MEDICINES PDF) Review of the available evidence on Lamotrigine for Epilepsy FOR THE WHO MODEL LIST OF ESSENTIAL MEDICINES](https://i1.rgstatic.net/publication/270886533_Review_of_the_available_evidence_on_Lamotrigine_for_Epilepsy_FOR_THE_WHO_MODEL_LIST_OF_ESSENTIAL_MEDICINES/links/54b790d80cf24eb34f6eb700/largepreview.png)
PDF) Review of the available evidence on Lamotrigine for Epilepsy FOR THE WHO MODEL LIST OF ESSENTIAL MEDICINES
![These highlights do not include all the information needed to use lamotrigine tablets safely and effectively. See full prescribing information for lamotrigine tablets.LAMOTRIGINE tablets for oral useInitial U.S. Approval: 1994 These highlights do not include all the information needed to use lamotrigine tablets safely and effectively. See full prescribing information for lamotrigine tablets.LAMOTRIGINE tablets for oral useInitial U.S. Approval: 1994](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=LAMOTRIGINE+100mg_802.jpg&id=45126)
These highlights do not include all the information needed to use lamotrigine tablets safely and effectively. See full prescribing information for lamotrigine tablets.LAMOTRIGINE tablets for oral useInitial U.S. Approval: 1994
![References in Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial - The Lancet Neurology References in Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2056015852/2061236457/gr2.gif)
References in Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial - The Lancet Neurology
![Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring in the United States | Business Wire Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring in the United States | Business Wire](https://mms.businesswire.com/media/20210114006024/en/739014/23/teva_RGB_JPEG.jpg)